Literature DB >> 12377264

Nicotine's oxidative and antioxidant properties in CNS.

Mary B Newman1, Gary W Arendash, R Douglas Shytle, Paula C Bickford, Thomas Tighe, Paul R Sanberg.   

Abstract

Nicotine has been reported to be therapeutic in some patients with certain neurodegenerative diseases and to have neuroprotective effects in the central nervous system. However, nicotine administration may result in oxidative stress by inducing the generation of reactive oxygen species in the periphery and central nervous system. There is also evidence suggesting that nicotine may have antioxidant properties in the central nervous system. The antioxidant properties of nicotine may be intracellular through the activation of the nicotinic receptors or extracellular by acting as a radical scavenger in that it binds to iron. The possibility that nicotine might be used to treat some symptoms of certain neurodegenerative diseases underlies the necessity to determine whether nicotine has pro-oxidant, antioxidant or properties of both. This review discusses the studies that have addressed this issue, the behavioral effects of nicotine, and the possible mechanisms of action that result from nicotine administration or nicotinic receptor activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377264     DOI: 10.1016/s0024-3205(02)02135-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  25 in total

1.  Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.

Authors:  Michelle G Baladi; Shannon M Nielsen; J Michael McIntosh; Glen R Hanson; Annette E Fleckenstein
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

2.  Brain Anatomy in Latino Farmworkers Exposed to Pesticides and Nicotine.

Authors:  Paul J Laurienti; Jonathan H Burdette; Jennifer Talton; Carey N Pope; Phillip Summers; Francis O Walker; Sara A Quandt; Robert G Lyday; Haiying Chen; Timothy D Howard; Thomas A Arcury
Journal:  J Occup Environ Med       Date:  2016-05       Impact factor: 2.162

3.  Prenatal nicotine increases matrix metalloproteinase 2 (MMP-2) expression in fetal guinea pig hearts.

Authors:  Loren P Thompson; Hongshan Liu; LaShauna Evans; Jessica A Mong
Journal:  Reprod Sci       Date:  2011-07-20       Impact factor: 3.060

Review 4.  Nicotine and inflammatory neurological disorders.

Authors:  Wen-Hua Piao; Denise Campagnolo; Carlos Dayao; Ronald J Lukas; Jie Wu; Fu-Dong Shi
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

5.  Antihyperlipidemic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, a curcumin analog, on nicotine and streptozotocin treated rats.

Authors:  Bandugula Venkata Reddy; J Sivagama Sundari; Elumalai Balamurugan; Venugopal Padmanabhan Menon
Journal:  Mol Cell Biochem       Date:  2009-09-30       Impact factor: 3.396

6.  Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Sophia M Fong; Bolanle Oluwadara; J Paul Finn; Danny Huang; Yvette Bordelon; Jim Mintz; Susan Perlman
Journal:  Neurochem Res       Date:  2007-05-05       Impact factor: 3.996

7.  CDP-choline prevents cardiac arrhythmias and lethality induced by short-term myocardial ischemia-reperfusion injury in the rat: involvement of central muscarinic cholinergic mechanisms.

Authors:  M Sertac Yilmaz; Cenk Coskun; Murat Yalcin; Vahide Savci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-27       Impact factor: 3.000

8.  Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?

Authors:  Dong-Pyo Hong; Anthony L Fink; Vladimir N Uversky
Journal:  Biochim Biophys Acta       Date:  2008-10-25

9.  Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.

Authors:  Camila Mouhape; Gustavo Costa; Margot Ferreira; Juan Andrés Abin-Carriquiry; Federico Dajas; Giselle Prunell
Journal:  Neurotox Res       Date:  2018-07-13       Impact factor: 3.911

10.  Nicotine decreases the cytotoxicity of doxorubicin towards MCF-7 and KB-3.1 human cancer cells in culture.

Authors:  Yanfei Zhou; Xinbin Gu; Ebrahim Ashayeri; Renshu Zhang; Rajagopalan Sridhar
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.